09:46 AM EST - Theratechnologies Inc. : Announced that new data featuring its investigational sortilin 1 (SORT1)-targeting peptide-drug conjugate technology will be presented in three posters at the American Association for Cancer Research’s virtual annual meeting II. Theratechnologies Inc.
shares T.TH are trading up $0.85 at $3.40.